Tonix Pharmaceuticals Announces Closing of $43.5 Million Public Offering of Common Stock
January 29, 2014 11:15 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the closing of its previously announced underwritten public offering of 2,898,550 shares...
Tonix Pharmaceuticals Prices Underwritten Public Offering Raising $43.5 Million
January 24, 2014 08:20 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 24, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced the pricing of an underwritten public offering of 2,898,550 shares of its common stock at...
Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
January 23, 2014 16:02 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Jan. 23, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, today announced that it intends to offer shares of...
Tonix Pharmaceuticals Announces the Enrollment of Completers From the BESTFIT Trial Into a 12-Month Open-Label Extension Study
December 10, 2013 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, announced today that it is enrolling subjects into...
Tonix Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
November 26, 2013 08:40 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 26, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 24th Annual Oppenheimer...
Tonix Pharmaceuticals to Present at the LD Micro Conference
November 21, 2013 09:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP), a development stage specialty pharmaceutical company, will be presenting at the 6th Annual LD Micro...
Tonix Pharmaceuticals Reports Third Quarter 2013 Financial Results
November 13, 2013 16:05 ET
|
Tonix Pharmaceuticals Holding Corp.
NEW YORK, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) today announced its financial results for the quarter ended September 30, 2013.
"The third quarter was...
Tonix Pharmaceuticals Completes Private Placement
December 05, 2012 08:36 ET
|
TONIX Pharmaceuticals Holding Corp.
NEW YORK, Dec. 5, 2012 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (OTCQB:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing novel treatments for challenging...
Tonix Pharmaceuticals to Present at Fifth Annual LD Micro Conference
December 05, 2012 08:33 ET
|
TONIX Pharmaceuticals Holding Corp.
NEW YORK, Dec. 5, 2012 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (OTCQB:TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing novel treatments for challenging...